 SAN DIEGO--BUSINESS WIRE--Ligand Pharmaceuticals Incorporated NASDAQ: LGND today reported financial results for the three- and nine-months ending September 30, 2020 and provided an operating forecast and program updates. Ligand management will host a conference call with slides today beginning at 8:30 a.m. Eastern time to discuss this announcement and answer questions. Our business is performing very well across the board. We are pleased to be reporting strong third quarter financial resul 